| Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer. (NCT07730151) | RenJi Hospital | 2026-08-01 |
| Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema (NCT07383701) | Massachusetts Eye and Ear Infirmary | 2026-08-01 |
| Study of Resmetirom in Children and Adolescents With MASH (NCT07763015) | Madrigal Pharmaceuticals, Inc. | 2026-08-01 |
| Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia (NCT07685717) | Jennifer Woyach | 2026-08-01 |
| Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer (NCT07637851) | ARCAGY/ GINECO GROUP | 2026-08-01 |
| RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia (NCT07596485) | Kriya Therapeutics, Inc. | 2026-08-01 |
| Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy (NCT07439406) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2026-08-01 |
| ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1 (NCT07472322) | University of Wisconsin, Madison | 2026-08-01 |
| A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) (NCT07748403) | Prime Medicine, Inc. | 2026-08-01 |
| Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis (NCT06463678) | IVIEW Therapeutics Inc. | 2026-08-01 |
| A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia (NCT07758920) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2026-08-01 |
| A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque Psoriasis (NCT07758075) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-01 |
| Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects (NCT07697443) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-08-01 |
| Elemene Liposomes in Endometrial Cancer (NCT07738315) | Women's Hospital School Of Medicine Zhejiang University | 2026-08-01 |
| Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma (NCT07657312) | Naresh Bumma | 2026-08-01 |
| A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer (NCT07691489) | Memorial Sloan Kettering Cancer Center | 2026-08-01 |
| Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder (NCT06807918) | University of Pennsylvania | 2026-08-01 |
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes (NCT07712562) | Dren Bio | 2026-08-01 |
| A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05) (NCT07739199) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-08-01 |
| Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence (NCT06885996) | University of Calgary | 2026-08-01 |
| SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL) (NCT07725705) | Institute of Hematology & Blood Diseases Hospital, China | 2026-08-01 |
| Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification (NCT07687004) | Institute of Hematology & Blood Diseases Hospital, China | 2026-08-01 |
| RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (NCT07645326) | Georgetown University | 2026-08-01 |
| GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the Lung (NCT07679607) | University of Maryland, Baltimore | 2026-08-01 |
| Gene Therapy Trial for CLN6 Batten Disease (NCT07582484) | The Charlotte and Gwenyth Gray Foundation | 2026-08-01 |
| Study of Oral MRT-2359 With Apalutamide in Prostate Cancer (NCT07745361) | Monte Rosa Therapeutics, Inc | 2026-08-01 |
| A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06) (NCT07739186) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-08-01 |
| The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma (NCT07560826) | Wake Forest University Health Sciences | 2026-08-01 |
| Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma. (NCT07686835) | Radboud University Medical Center | 2026-07-31 |
| Study of Robotic Assisted/Image Guided Electromagnetic Navigation Bronchoscopic Therapies and Surgery in Stage IA NSCLC (NCT07741344) | Chinese University of Hong Kong | 2026-07-31 |
| Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer (NCT05521997) | Washington University School of Medicine | 2026-07-31 |
| NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab (NCT07261241) | New Approaches to Neuroblastoma Therapy Consortium | 2026-07-31 |
| A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC) (NCT07622186) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-07-31 |
| Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis (NCT07746180) | Chinese PLA General Hospital | 2026-07-31 |
| Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma (NCT07645846) | Sun Yat-sen University | 2026-07-31 |
| Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD (NCT07222553) | Amgen | 2026-07-31 |
| A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants (NCT07668154) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-07-31 |
| Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL) (NCT07717580) | Peking University First Hospital | 2026-07-31 |
| Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC (NCT07733830) | Tianjin Medical University Cancer Institute and Hospital | 2026-07-31 |
| Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (NCT07689292) | Tianjin Medical University Cancer Institute and Hospital | 2026-07-31 |
| Neoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or Without Ipilimumab N01 in Resectable Gastric/Gastroesophageal Junction Adenocarcinoma (NCT07643623) | Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 2026-07-31 |
| Luvometinib in Combination With Serplulimab for NF2-Related Tumors (NCT07708285) | Beijing Tiantan Hospital | 2026-07-31 |
| Radiation Therapy Approaches for People With Prostate Cancer (NCT07751159) | Memorial Sloan Kettering Cancer Center | 2026-07-31 |
| Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma (NCT07673367) | Vanderbilt-Ingram Cancer Center | 2026-07-31 |
| Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL (NCT07744724) | Changzhou No.2 People's Hospital | 2026-07-31 |
| Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults (NCT07703956) | Vigonvita Life Sciences | 2026-07-31 |
| A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) (NCT07595042) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-07-31 |
| Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer (NCT07593079) | Washington University School of Medicine | 2026-07-31 |
| Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels (NCT07360743) | UNICANCER | 2026-07-30 |
| Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD (NCT07435129) | Scholar Rock, Inc. | 2026-07-30 |
| Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain (NCT07035119) | Medical University of South Carolina | 2026-07-30 |
| A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors (NCT07704866) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2026-07-30 |
| HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB (NCT07575308) | Alnylam Pharmaceuticals | 2026-07-30 |
| Rademikibart IV for Acute Asthma and COPD Exacerbation (NCT07705737) | Connect Biopharm LLC | 2026-07-30 |
| Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease (NCT07346157) | Sabine Mueller, MD, PhD | 2026-07-30 |
| Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG (NCT07611435) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-07-30 |
| Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG (NCT07216391) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-07-30 |
| Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study (NCT07739485) | Liu Shu | 2026-07-30 |
| Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast Cancer (NCT07752550) | Harbin Medical University | 2026-07-30 |
| QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer (NCT07636226) | Sun Yat-sen University | 2026-07-30 |
| A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR) (NCT07681271) | Novartis Pharmaceuticals | 2026-07-30 |
| A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G (NCT06419205) | Akebia Therapeutics | 2026-07-30 |
| Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer (NCT07441369) | Fudan University | 2026-07-30 |
| SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma (NCT07700667) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-07-30 |
| Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL (NCT07744737) | Changzhou No.2 People's Hospital | 2026-07-30 |
| A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a) (NCT07640217) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2026-07-30 |
| A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old (NCT07722546) | Biogen | 2026-07-30 |
| Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma (NCT06418724) | Melanoma and Skin Cancer Trials Limited | 2026-07-30 |
| A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG) (NCT07673744) | TG Therapeutics, Inc. | 2026-07-30 |
| A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (NCT07749586) | Arvinas Inc. | 2026-07-29 |
| A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis (NCT07684157) | Jacobio Pharmaceuticals Co., Ltd. | 2026-07-29 |
| The Progressive Supranuclear Palsy Clinical Trial Platform (NCT07173803) | Adam Boxer | 2026-07-29 |
| Capecitabine in ER+/HER2-negative Breast Cancer (NCT07631052) | University Health Network, Toronto | 2026-07-29 |
| The Efficacy and Safety of Trastuzumab Deruxtecan in Advanced or Metastatic NSCLC With HER2 Over Expression (NCT07662473) | Hunan Province Tumor Hospital | 2026-07-29 |
| A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors (NCT07669415) | LaNova Medicines Limited | 2026-07-29 |
| Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT (NCT07455903) | Baptist Health South Florida | 2026-07-29 |
| The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1 (NCT07217665) | Adam Boxer | 2026-07-29 |
| Study of EVO756 in Adults With Migraine (NCT07616128) | Evommune, Inc. | 2026-07-29 |
| Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study (NCT07766837) | Hartford Hospital | 2026-07-29 |
| Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes (NCT07685808) | Regeneron Pharmaceuticals | 2026-07-29 |
| Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study (NCT07739511) | Liu Shu | 2026-07-29 |
| The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31 (NCT07264283) | Adam Boxer | 2026-07-29 |
| A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer (NCT07659795) | Verastem, Inc. | 2026-07-28 |
| A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus (NCT07630714) | AstraZeneca | 2026-07-28 |
| Optimizing PreTerm Infant Ampicillin Dosing (NCT07610486) | Duke University | 2026-07-28 |
| A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria (NCT07545681) | GlaxoSmithKline | 2026-07-28 |
| A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC (NCT07586202) | Janssen Research & Development, LLC | 2026-07-28 |
| A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease (NCT07688213) | Sanofi | 2026-07-28 |
| SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study (NCT07700719) | Peking University Cancer Hospital & Institute | 2026-07-28 |
| A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants (NCT07730554) | AbbVie | 2026-07-28 |
| A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery (NCT07694375) | Caravel Oculus Pty Ltd | 2026-07-28 |
| B-PaLMZ for TB Meningitis (NCT07227779) | David Boulware | 2026-07-28 |
| Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial (NCT07738523) | Hospital Universitario Getafe | 2026-07-27 |
| Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis (NCT07736495) | Ain Shams University | 2026-07-27 |
| Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT) (NCT07601425) | Atavistik Bio, Inc | 2026-07-27 |
| A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) (NCT07492680) | Bristol-Myers Squibb | 2026-07-27 |
| Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow (NCT06492486) | Tata Memorial Centre | 2026-07-27 |
| Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion (NCT07573163) | Alaa Sada | 2026-07-27 |
| A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (NCT07725939) | UCB Biopharma SRL | 2026-07-27 |
| CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children (NCT07023744) | University of Manitoba | 2026-07-27 |